• Promising results with exemestane in the first-line treatment of metastatic breast cancer: a randomized phase II EORTC trial with a tamoxifen control.
Auteur:Paridaens, R.; Dirix, Luc Y; Beex, Louk; Nooij, Marianne; Cufer, T; Lohrisch, C; Biganzoli, Laura; Van Hoorebeeck, Irène; Duchateau, L; Lobelle, Jean Pierre; Piccart-Gebhart, Martine
Informations sur la publication:Clinical breast cancer, 1 Suppl 1, page (S19-S21)
Statut de publication:Publié, 2000-09
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Administration, Oral
Androstadienes -- adverse effects
Androstadienes -- therapeutic use
Antineoplastic Agents, Hormonal -- therapeutic use
Aromatase Inhibitors -- adverse effects
Aromatase Inhibitors -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Disease Progression
Neoplasm Metastasis
Tamoxifen -- therapeutic use
Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't